![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, March 21, 2017 8:28:02 AM
The other thing we are trying to do is in the future consider registration of our products in our own label and trying to put products in the market, particularly the ANDAs (Abbreviated New Drug Application), the generic products, to sell them ourselves. Those are the challenges that we see from day to day when we’re trying to put products on the market.
I wonder if this is the plan with Keppra and Glucophage
But we filed recently two products in Canada.
No PR, would be nice to know which two. Whats approval times for Canada like?
Its nice to see a increase in communication from the company. I don't know why some of it isn't issued in PR's though. The submissions to Canada seem to be PR worthy to me.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM